PODD
Insulet CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$10.73B
P/E Ratio
36.27
EPS
$4.27
Beta
1.20
52W High
$354.88
52W Low
$145.59
50-Day MA
$189.65
200-Day MA
$272.24
Dividend Yield
—
Profit Margin
10.40%
Forward P/E
25.00
PEG Ratio
1.21
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.90B |
| Gross Profit (TTM) | $2.06B |
| EBITDA | $602.00M |
| Operating Margin | 16.00% |
| Return on Equity | 23.00% |
| Return on Assets | 9.74% |
| Revenue/Share (TTM) | $41.28 |
| Book Value | $21.53 |
| Price-to-Book | 8.34 |
| Price-to-Sales (TTM) | 3.70 |
| EV/Revenue | 3.907 |
| EV/EBITDA | 20.09 |
| Quarterly Earnings Growth (YoY) | 159.00% |
| Quarterly Revenue Growth (YoY) | 33.90% |
| Shares Outstanding | $69.27M |
| Float | $69.00M |
| % Insiders | 0.31% |
| % Institutions | 105.41% |
Historical Volatility
HV 10-Day
41.89%
HV 20-Day
77.20%
HV 30-Day
64.56%
HV 60-Day
50.15%
HV Rank
99.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($246.79 target)
5
Strong Buy15
Buy3
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026